Hormone Receptor-Positive Breast Cancer

Hormone receptor-positive breast cancer represents the most common subtype worldwide. This session examines endocrine therapy, resistance mechanisms, genomic assays, and long-term disease management. Experts will discuss personalized endocrine treatment strategies and biomarker-guided therapy selection. Emerging therapeutic agents and combination treatments will also be reviewed. The session emphasizes optimizing outcomes through precision medicine.

    Related Conference of Hormone Receptor-Positive Breast Cancer

    July 23-24, 2026

    6th World Pathology Conference

    Amsterdam, Netherlands
    March 25-26, 2027

    25th European Pathology Congress

    Paris, France
    March 29-30, 2027

    25th Annual Pathology Congress

    Dubai, UAE

    Hormone Receptor-Positive Breast Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in